Please use this identifier to cite or link to this item: http://repositorio.ufc.br/handle/riufc/7232
Type: Artigo de Periódico
Title: Arylamino-nor-b-lapachone derivative-induced apoptosis in human prostate cancer cells: involvement of NAD(P)H :quinone oxidoreductase (NQO1)
Authors: Cavalcanti, Bruno C.
Magalhães, Hemerson I. F.
Rodrigues, Felipe A. R.
Moraes Filho, Manoel Odorico de
Pessoa, Cláudia
Keywords: Apoptose;Neoplasias da Próstata
Issue Date: Apr-2013
Publisher: BMC Proceedings
Citation: CAVALCANTI, B. C. et al. Arylamino-nor-b-lapachone derivative-induced apoptosis in human prostate cancer cells : involvement of NAD(P)H quinone oxidoreductase (NQO1). BMC Proceedings, São Paulo, SP, v. 7, supl. 2, p. 12-12, abr. 2013.
Abstract: b-lapachone, a DNA repair inhibitor, has been recognized as important prototype with activity against cancer cells devoided of cytotoxicity in non-tumor cells. NQO1 is a reductive enzyme that is important for the activation of many bioreductive quinones. Thus, differential levels of NQO1 in tissues, including tumors, can provide a target for an enzyme-directed approach to cancer therapy. Herein, we aimed to evaluate the role of NQO1 on the cytotoxicity of 3-arylamino-nor-b-lapachone derivative using the prostate DU-145 (NQO1-overexpressing) and LNCap (NQO1-deficient) cells.
URI: http://www.repositorio.ufc.br/handle/riufc/7232
Appears in Collections:DFIFA - Artigos publicados em revista científica

Files in This Item:
File Description SizeFormat 
2013_art_bccavalcanti.pdf160,74 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.